selected publications
-
academic article
- Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database. Prostate Cancer and Prostatic Diseases. 2017
- 911PPatients (pts) with metastatic non-clear cell renal cell carcinoma (mnccRCC) treated with Nivolumab (Nivo) based immunotherapy as advanced treatment (ATL) line: analysis of a national early access program (EAP). Annals of Oncology. 28. 2017
- Circulating Cell-Free DNA Levels in Patients with Metastatic Renal Cell Carcinoma. Oncology Research and Treatment. 40:707-710. 2017
- Rapid Response to Nivolumab in a Patient With Sarcomatoid Transformation of Chromophobe Renal Cell Carcinoma. Clinical Genitourinary Cancer. 15. 2017
- Testicular Metastasis from Renal Cell Carcinoma: A Case Report and Review of the Literature. Case Reports in Oncology. 10:388-391. 2017
- Comparison of sunitinib versus temsirolimus in patients with poor risk metastatic renal cell carcinoma. European Urology Supplements. 15:e1740. 2016
- Outcome of octogenarian versus young patients with metastatic renal cell carcinoma, treated with sunitinib. European Urology Supplements. 15:e1741. 2016
- Ipilimumab Treatment-Induced Distal Esophageal Dissection in a Patient with Advanced Prostate Cancer. The Israel Medical Association journal: IMAJ. 18:435-436. 2016
- Comparison of abiraterone acetate (Abi) versus ketoconazole (Keto) in chemotherapy-naive patients (CN-pts) with metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 34:260-260. 2016
- Comparison of sunitinib (su) versus temsirolimus (tem) in patients (pts) with poor-risk metastatic renal cell carcinoma (prmRCC).. Journal of Clinical Oncology. 34:539-539. 2016
- Imaging response during therapy (tx) with radium-223 (Ra-223) for castrate resistant prostate cancer (CRPC) with bone metastases (BM).. Journal of Clinical Oncology. 34:282-282. 2016
- Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 14:420-425. 2016
- Outcome of octogenarian versus (vs) young patients (pts) with metastatic renal cell carcinoma (mRCC), treated with sunitinib (su).. Journal of Clinical Oncology. 34:538-538. 2016
- Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib. Annals of Oncology. 27:1212-1217. 2016
- Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?. Cancer Research and Treatment. 48:281-287. 2015
- Metformin use and outcome of sunitinib treatment in diabetic patients with metastatic renal cell carcinoma.. Journal of Clinical Oncology. 33:440-440. 2015
- Patients with metastatic chromophobe renal cell carcinoma treated with sunitinib therapy: Analysis of an international database regarding outcome and comparison to clear cell histology (mccRCC).. Journal of Clinical Oncology. 33:429-429. 2015
- Primitive Neuroectodermal Tumor of the Kidney: A Case Report.. Clinical Genitourinary Cancer. 13. 2015
- Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib. The oncologist. 19:51-60. 2014
- Clinicopathologic factors associated with the development of sunitinib induced hypertension (HTN) in patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 32:508-508. 2014
- Patients with metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (tx): Results from an international metastatic RCC database.. Journal of Clinical Oncology. 32:486-486. 2014
- Potential impact of prior high-dose IL-2 on the outcomes of sunitinib (Su) treatment (tx) in patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 32:494-494. 2014
- Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)?. Journal of Clinical Oncology. 31:458-458. 2013
- Influence of concurrent medications on PSA doubling time (PSADT) in patients (pts) with nonmetastatic biochemically relapsed prostate cancer (BRPC M0) after local therapy (tx).. Journal of Clinical Oncology. 31:160-160. 2013
- Is there a "trial effect" on outcome of patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib?. Journal of Clinical Oncology. 31:453-453. 2013
- Toxic Epidermal Necrolysis Associated with Gemcitabine Therapy in a Patient with Metastatic Transitional Cell Carcinoma of the Bladder. Journal of chemotherapy (Florence, Italy). 15:510-511. 2013
- Localization of PKC? in Cell Membranes as a Predictor for Breast Cancer Response to Treatment. Oncology Research and Treatment. 35:260-266. 2012
- Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model. British journal of cancer. 107:814-822. 2012
- Successful Treatment of Mediastinal Seminoma in a Hemodialysis Patient. Onkologie. 35:275-278. 2012
- 5152 The prognostic importance of various clinical, pathological, and immunohistochemical parameters in tamoxifen-treated patients with early breast cancer. EJC Supplements. 7:305-306. 2009
- Is Prostate Cancer Screening Justified in the Bedouin Population?. Onkologie. 32:260-262. 2009
- Ethnicity and its significance in the pathobiology of prostatic carcinoma in Southern Israel.. Urologic Oncology: Seminars and Original Investigations. 26:31-36. 2008
- Pulmonary Sarcoidosis Mimicking Metastases in Breast Cancer Patients. Onkologie. 30:327-328. 2007
- Retrospective comparison of two different schedules of irinotecan, 5-fluorouracil and folinic acid in previously untreated patients with advanced colorectal carcinoma: a single institution experience.. Journal of chemotherapy (Florence, Italy). 19:739-743. 2007
- Serous papillary adenocarcinoma of the rete testis: Unusual ultrasonography and pathological findings. Journal of cancer research and therapeutics. 3:37-9. 2007
- Prospective Study of Empiric Monotherapy with Ceftazidime for Low-Risk Grade IV Febrile Neutropenia after Cytotoxic Chemotherapy in Cancer Patients. Chemotherapy. 52:185-189. 2006
- Cutaneous photosensitivity induced by paclitaxel and trastuzumab therapy associated with aberrations in the biosynthesis of porphyrins.. Journal of dermatological treatment. 16:19-21. 2005
- Preoperative Radio-Chemotherapy Treatment in Locally Advanced Rectal Carcinoma. Results of 8-Year Follow-Up. Onkologie. 28:267-269. 2005
- Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Urology. 63:398-401. 2004
- Preoperative radiochemotherapy treatment in advanced rectal carcinoma. Results of 8-year follow up. Journal of Clinical Oncology. 22:3634-3634. 2004
- Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy.. International Journal of Cancer. 110:260-265. 2004
- Accuracy of prostate radiation therapy using a fiducial point-pair registration technique based on the computer-assisted portal imaging quality assurance program PIPSpro.. Journal of Medical Imaging and Radiation Oncology. 47:168-171. 2003
- Modified M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Chemotherapy for Advanced Transitional Cell Carcinoma of the Urothelium. UroOncology. 3:13-16. 2003
- Perioperative Homologous Blood Transfusion and Survival in Patients with Surgically Treated Renal Cell Carcinoma. UroOncology. 3:23-25. 2003
- Small bowel adenocarcinoma in crohn disease patient complicated by microangiopathic hemolytic anemia.. American Journal of Clinical Oncology. 26:483-485. 2003
- Cutaneous angiosarcoma of breast after lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast carcinoma: case report and review of the literature.. American Journal of Clinical Oncology. 25:597-598. 2002
- Influence of Age on the Prognosis of Patients with Renal Cell Carcinoma (RCC). Onkologie. 25:548-550. 2002
- Primary Bilateral Adrenal Lymphoma Relapsing as a Solid Cerebral Mass After Complete Clinical Remission. American Journal of Clinical Oncology. 24:583-5. 2002
- Retrospective Comparison of Single-Agent Chemotherapy with Weekly 5-Fluorouracil or Weekly Irinotecan in Previously Treated Patients with Metastatic Colorectal Cancer. Journal of chemotherapy (Florence, Italy). 14:84-87. 2002
- Acute Myocardial Infarction in a Young Man Receiving Chemotherapy for Testicular Cancer: Case Report. Journal of chemotherapy (Florence, Italy). 13:658-660. 2001
- Primary Malignant Lymphoma of the Prostate - A Report of Three Cases. Leukemia and Lymphoma. 42:809-811. 2001
- Cutaneous photosensitivity associated with abberations in the heme biosynthetic pathway induced by taxanes (T) and trastuzumab (H): A report of 3 cases of metastatic breast cancer.. Annals of Oncology. 11:28-28. 2000
- Direct extracranial spread of a brain metastasis through a craniotomy defect. Medical and Pediatric Oncology. 34:74-75. 2000
- Phase II study of weekly high dose fluorouracil in previously treated patients with metastatic colorectal cancer.. Journal of chemotherapy (Florence, Italy). 12:183-185. 2000
- Extremely Elevated CA19-9 serum level in a patient with acute biliary obstruction and chronic cholecystitis. Journal of Tumor Marker Oncology. 13:41-42. 1998
- Metastatic angiosarcoma of the spleen after accidental radiation exposure - A case report. American Journal of Clinical Oncology. 21:167-170. 1998
- Chemoimmunotherapy treatment of progressive disseminated melanoma patients, induced extension in survival: 406. Melanoma Research. 7. 1997
- Debris containing cystic transformation of melanoma metastatic lesions following chemoimmuno-therapy: 409. Melanoma Research. 7. 1997
- Combined acute aortic thrombosis and metastatic spinal cord compression causing paraplegia in a patient with small-cell lung carcinoma (SCLC). Annals of Oncology. 7:321-322. 1996
- Case Report: Serendipitous Gaucher's Disease Presenting as Elevated Erythrocyte Sedimentation Rate Due to Monoclonal Gammopathy. UroOncology. 301:111-112. 1991
-
conference paper
- An impact of pelvic MRI (PMRI) to radiotherapy (RT) target volumes definition in prostate cancer patients (pts).. Journal of Clinical Oncology. 2015